Disc Medicine Stock (NASDAQ: IRON) stock price, news, charts, stock research, profile.
Open | $31.790 |
Close | $31.920 |
Volume / Avg. | 228.823K / 491.993K |
Day Range | 31.100 - 32.250 |
52 Wk Range | 25.600 - 77.600 |
Market Cap | $789.116M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 7.91% |
Days to Cover | 4.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Disc Medicine (NASDAQ: IRON) through any online brokerage.
Other companies in Disc Medicine’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA), Cogent Biosciences (NASDAQ:COGT) and Zentalis Pharma (NASDAQ:ZNTL).
The latest price target for Disc Medicine (NASDAQ: IRON) was reported by Cantor Fitzgerald on Wednesday, May 15, 2024. The analyst firm set a price target for 85.00 expecting IRON to rise to within 12 months (a possible 166.29% upside). 23 analyst firms have reported ratings in the last year.
The stock price for Disc Medicine (NASDAQ: IRON) is $31.92 last updated May 16, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Disc Medicine.
Disc Medicine’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Disc Medicine.
Disc Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.